Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphomaJacky Y. K. Ho, David Allan, Michael Halpenny et al.|Bone Marrow Transplantation|2008Cited by 34
Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantationSarah Takach, David Allan, Lin Yang et al.|Bone Marrow Transplantation|2009Cited by 0